I-45678: Genomic markers in acute leukemia Provisioned
Dr. Henrik Solberg, Hematologic Oncology. IRB protocol IRB-2026-0217, approved 2026-08-30 through 2027-08-29.
Approved scope
Cohort
Leukemia (ICD-10 C91 and C92)
Variables
Demographics (birth year, sex, ZIP3), diagnoses, labs
Date range
2008-01-01 to 2026-06-30
Identifiers released
None (de-identified, date shifted)
Data use
Biomarker discovery
Retention
36 months, then disposition
Honest broker
J. Whitcomb
Workspace
research-I45678 (export disabled, onward sharing blocked)
Approval trail
- Submitted by Dr. Henrik Solberg (Principal investigator)
2026-08-12 13:10
Request submitted with IRB protocol IRB-2026-0217. - IRB approved by IRB Office (IRB)
2026-08-30 10:00
Approved through 2027-08-29. - Approved by Data Governance Council (Data owner)
2026-09-02 14:45
Data use agreement DUA-2026-097 signed; retention 36 months. - Provisioned by J. Whitcomb (Honest broker)
2026-09-03 09:30
Study workspace research-I45678 created; study identifiers generated.
Audit trail for I-45678
| Time | Actor | Action | Detail |
|---|---|---|---|
| 2026-09-03 09:30 | J. Whitcomb | Provision | Study identifiers generated; crosswalk stored in linkage service |